Research chair named after Dr. Salem

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 19 No 9
Volume 19
Issue 9

St. Luke’s Episcopal Hospital has established the Philip A. Salem, MD, Chair in Cancer Research.


PHILIP A. SALEM, MD

St. Luke's Episcopal Hospital has established the Philip A. Salem, MD, Chair in Cancer Research. This is the first chair in cancer research established at the Houston-based hospital which is part of the Texas Medical Center.

Dr. Salem is the director of the cancer research program at St. Luke's. His groundbreaking work in chemoprevention, including the link between chronic gastrointestinal infections and the risk of cancer, has led to research focusing on isolating and treating precancerous infections.

Related Videos
Immunotherapy may be an “elegant” method of managing colorectal cancer, says Gregory Charak, MD.
Administering neoadjuvant therapy to patients with colorectal cancer may help surgical oncologists attain a negative-margin resection.
Increasing screening for younger individuals who are at risk of colorectal cancer may help mitigate the rising early incidence of this disease.
Laparoscopy may reduce the degree of pain or length of hospital stay compared with open surgery for patients with colorectal cancer.
Quantifying disease volume to help identify potential recurrence following surgery may be a helpful advance, according to Sean Dineen, MD.
A panel of 5 experts on colorectal cancer
A panel of 5 experts on colorectal cancer
A panel of 5 experts on colorectal cancer
Treatment options in the refractory setting must improve for patients with resected colorectal cancer peritoneal metastasis, says Muhammad Talha Waheed, MD.
Arvind N. Dasari, MD, MS, an expert on colorectal cancer